Publicacións nas que colabora con Amparo Larrauri Cámara (2)

2024

  1. Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain

    Influenza and other Respiratory Viruses, Vol. 18, Núm. 5

  2. Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 years

    Journal of Infection, Vol. 89, Núm. 5